MAPT and progressive supranuclear palsy: Counterintuitively, it seems that P-tau181 is largely a plaque amyloid marker52: it does not go up in progressive supranuclear palsy, it goes up in amyloid mice after onset of plaque pathology53 (although it may also increase in tau-overexpressing mice54).